Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Greenberg

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2003
Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscleDespina Sanoudou, Judith N Haslett, Alvin T Kho, et al.
BMC Medical Genomics|November 23, 2012
Genomic signatures characterize leukocyte infiltration in myositis musclesWei Zhu, Katie Streicher, Nan Shen, et al.
Annals of the Rheumatic Diseases|August 2, 2011
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathwayBrandon W Higgs, Zheng Liu, Barbara White, et al.
Immunohorizons|June 20, 2020
TLR Stimulation Produces IFN-β as the Primary Driver of IFN Signaling in Nonlymphoid Primary Human CellsRyan Nistler, Ankur Sharma, Katrina Meeth, et al.
Annals of Neurology|April 27, 2005
Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositisSteven A Greenberg, Jack L Pinkus, Geraldine S Pinkus, et al.
Neurology|November 9, 2014
Treatment of sporadic inclusion body myositis with bimagrumabAnthony A Amato, Kumaraswamy Sivakumar, Namita Goyal, et al.
Journal of Autoimmunity|July 1, 2019
Cytotoxic KLRG1 expressing lymphocytes invade portal tracts in primary biliary cholangitisYikang Li, Bo Li, Zhengrui You, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathiesRobert W Georgantas, Katie Streicher, Steven A Greenberg, et al.
Annals of the Rheumatic Diseases|February 26, 2013
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patientsBrandon W Higgs, Wei Zhu, Chris Morehouse, et al.
Neurology|February 8, 2022
Immunophenotyping of Inclusion Body Myositis Blood T and NK CellsNamita A Goyal, Gérald Coulis, Jorge Duarte, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2003
Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscleDespina Sanoudou, Judith N Haslett, Alvin T Kho, et al.
BMC Medical Genomics|November 23, 2012
Genomic signatures characterize leukocyte infiltration in myositis musclesWei Zhu, Katie Streicher, Nan Shen, et al.
Annals of the Rheumatic Diseases|August 2, 2011
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathwayBrandon W Higgs, Zheng Liu, Barbara White, et al.
Immunohorizons|June 20, 2020
TLR Stimulation Produces IFN-β as the Primary Driver of IFN Signaling in Nonlymphoid Primary Human CellsRyan Nistler, Ankur Sharma, Katrina Meeth, et al.
Annals of Neurology|April 27, 2005
Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositisSteven A Greenberg, Jack L Pinkus, Geraldine S Pinkus, et al.
Neurology|November 9, 2014
Treatment of sporadic inclusion body myositis with bimagrumabAnthony A Amato, Kumaraswamy Sivakumar, Namita Goyal, et al.
Journal of Autoimmunity|July 1, 2019
Cytotoxic KLRG1 expressing lymphocytes invade portal tracts in primary biliary cholangitisYikang Li, Bo Li, Zhengrui You, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathiesRobert W Georgantas, Katie Streicher, Steven A Greenberg, et al.
Annals of the Rheumatic Diseases|February 26, 2013
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patientsBrandon W Higgs, Wei Zhu, Chris Morehouse, et al.
Neurology|February 8, 2022
Immunophenotyping of Inclusion Body Myositis Blood T and NK CellsNamita A Goyal, Gérald Coulis, Jorge Duarte, et al.
Pageof 11